Your English writing platform
Discover LudwigSuggestions(1)
Exact(1)
The proportion of rats developing tumours were lower in HAMS and HAMSB than LAMS (P < 0.05), and the number of tumours per rat were lower in HAMSB than LAMS (P < 0.05).
Similar(59)
The total tumour area for each rat was lower in the HAMBS than LAMS group (P < 0.05).
As shown in Fig. 6A, PPP 5-HT levels in rSey2/+ male rats were lower than in WT (t-test: P<0.05).
Mean glucose concentrations for exenatide-treated rats were lower than those observed in control animals and increased by 1.6- to 2-fold above that of pre-treatment levels.
The fluid and food intake as well as BW (Table 2) and EUV) in the SMV-exposed rats were lower, compared with the control animals.
SOD and CAT results were similar to that of the oxidative stress biomarkers, but inversely, so the values of SOD and CAT in the cirrhotic rats were lower than in the normal rats.
At 25 weeks of age, the mRNA levels of nephrin and podocin in vehicle-treated OLETF rats were lower than those in LETO rats in superficial and juxtamedullary glomeruli.
Western blot analysis showed that the levels of cardiac phospho (p -AMPK and p -AMPKn OLETF rand were lower than in LETO rats and that they increased after ALA administration (p < 0.05).
Although tumour incidence rates in female rats were lower than in males, they were highly significant at the highest dose (16%); here the historical control rate was less than 0.3%.
Peak vertical force and vertical impulse of MMT rats were lower in the operated limb relative to the contralateral limb (P = 0.016; P = 0.003, respectively, Figure 5, left column).
STZ rats n = 8, Control rats n = 8 # P < 0.05 STZ rats versus Control rats for baseline values; * P < 0.05 versus the baseline value Resting HR, MAP, SBP-LF, HR-HF, HR-LF/HF ratios in STZ rats were lower than those in control rats.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com